Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001078889 | SCV001097850 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2024-09-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004018972 | SCV002701682 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Martin Pollak Laboratory, |
RCV000054616 | SCV000077306 | unknown | not provided | no assertion criteria provided | not provided | Converted during submission to Uncertain significance. |